review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1052540676 |
P356 | DOI | 10.1186/1750-1172-2-15 |
P932 | PMC publication ID | 1847677 |
P698 | PubMed publication ID | 17389039 |
P2093 | author name string | Soon Koo Baik | |
Samuel S Lee | |||
Tamer R Fouad | |||
P2860 | cites work | Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle | Q31136248 |
Cardiopulmonary dysfunction in cirrhosis. | Q33672187 | ||
Cirrhotic cardiomyopathy and liver transplantation | Q33983997 | ||
Coronary artery disease and liver transplantation: the state of the art. | Q33984005 | ||
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity | Q34275352 | ||
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease | Q34467402 | ||
Nitric oxide and renal and cardiac dysfunction in cirrhosis | Q34521737 | ||
Hemodynamic correlates of outcome in patients undergoing orthotopic liver transplantation. Evidence for early postoperative myocardial depression | Q72389091 | ||
Is there a cirrhotic cardiomyopathy? | Q73234040 | ||
Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy | Q73420900 | ||
Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis | Q73644914 | ||
Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation | Q73744089 | ||
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites | Q73856981 | ||
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors | Q74027068 | ||
Post-liver transplantation myocardial dysfunction | Q77182453 | ||
Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS) | Q77540935 | ||
Dyssynchronous electrical and mechanical systole in patients with cirrhosis | Q77908527 | ||
Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis | Q78176757 | ||
Cirrhotic cardiomyopathy | Q78520606 | ||
Cardiac dysfunction in spontaneous bacterial peritonitis: A manifestation of cirrhotic cardiomyopathy? | Q79209018 | ||
Cardiac alterations in cirrhosis: reversibility after liver transplantation | Q81223866 | ||
The cardiac output at rest in Laennec's cirrhosis | Q35258043 | ||
Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt | Q35355011 | ||
The cardiac response to exercise in cirrhosis | Q35364575 | ||
Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopathy | Q35568074 | ||
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. | Q35596013 | ||
Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt | Q35953809 | ||
Cardiac morbidity and mortality related to orthotopic liver transplantation. | Q35959916 | ||
Cardiac electrophysiological abnormalities in patients with cirrhosis | Q36410682 | ||
Therapy insight: Cirrhotic cardiomyopathy | Q36495176 | ||
Cardiovascular determinants of survival in cirrhosis | Q36829265 | ||
Liver transplantation (2). | Q38699980 | ||
Cardiac abnormalities in liver cirrhosis | Q38746072 | ||
Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop | Q40473385 | ||
Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis | Q40536256 | ||
The hemodynamic response to exercise in patients with Laennec's cirrhosis | Q40993985 | ||
Cirrhotic cardiomyopathy: getting to the heart of the matter | Q41021596 | ||
Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity | Q41976384 | ||
Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. | Q42003359 | ||
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats | Q42200119 | ||
Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats | Q42516553 | ||
Cirrhotic cardiomyopathy: an endocannabinoid connection? | Q43261370 | ||
Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. | Q43512658 | ||
Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy | Q43777318 | ||
Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis | Q43785988 | ||
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis | Q44231605 | ||
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. | Q44632315 | ||
Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation | Q44972397 | ||
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis | Q46447287 | ||
Circulatory function and hepatorenal syndrome in cirrhosis. | Q46565582 | ||
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction | Q48298813 | ||
Plasma levels of brain natriuretic peptide in patients with cirrhosis | Q48459198 | ||
Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? | Q48703428 | ||
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy | Q48853320 | ||
Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. | Q53762740 | ||
Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. | Q54103967 | ||
Mechanism of nitric oxide-induced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx. | Q54106152 | ||
Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats. | Q54434474 | ||
Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. | Q54639652 | ||
Elevated circulating cardiac troponin I in patients with cirrhosis. | Q54645715 | ||
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt | Q57004208 | ||
Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct–ligated rats | Q58308584 | ||
What happens to cirrhotic cardiomyopathy after liver transplantation? | Q58308638 | ||
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis | Q59654600 | ||
Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction | Q61577424 | ||
Membrane fluidity and transport properties in epithelia | Q67507471 | ||
Limited cardiac preload reserve in conscious cirrhotic rats | Q67692995 | ||
Fatal torsade de pointes occurring in a patient receiving intravenous vasopressin and nitroglycerin | Q67907785 | ||
Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats | Q68477905 | ||
Echocardiographic findings before and after liver transplantation | Q69891360 | ||
Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver | Q70635876 | ||
Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation | Q71023569 | ||
Prolongation of the QTc-interval reflects the severity of autonomic neuropathy in primary biliary cirrhosis and in other non-alcoholic liver diseases | Q71547130 | ||
Left ventricular diastolic function in liver cirrhosis | Q71596534 | ||
Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related | Q71603519 | ||
Hemodynamic effects of dobutamine in patients with alcoholic cirrhosis | Q71761975 | ||
Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats | Q72101412 | ||
Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance | Q72198313 | ||
High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting | Q72236984 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver cirrhosis | Q147778 |
cardiomyopathy | Q847583 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 15 | |
P577 | publication date | 2007-03-27 | |
P1433 | published in | Orphanet Journal of Rare Diseases | Q15756117 |
P1476 | title | Cirrhotic cardiomyopathy | |
P478 | volume | 2 |
Q37892712 | A perspective on cirrhotic cardiomyopathy |
Q35308671 | Arrhythmia risk in liver cirrhosis. |
Q92982272 | Association of Cirrhosis and Cardiomyopathy |
Q50972269 | Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. |
Q41818548 | Cardiac dysfunction in liver cirrhosis: A tissue Doppler imaging study from Egypt |
Q38724506 | Cardiac manifestations in alcoholic liver disease |
Q38267664 | Cardiohepatic syndrome |
Q53058927 | Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice. |
Q27010592 | Cardiovascular dysfunction in patients with liver cirrhosis |
Q41650209 | Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome |
Q26778048 | Cirrhotic cardiomyopathy |
Q40029009 | Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis? |
Q38268611 | Cirrhotic cardiomyopathy: a cardiologist's perspective |
Q38249191 | Cirrhotic cardiomyopathy: review of pathophysiology and treatment |
Q64245031 | Cirrhotic cardiomyopathy: the liver affects the heart |
Q35833011 | Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis |
Q36662684 | Evaluation of cardiac functions of cirrhotic children using serum brain natriuretic peptide and tissue Doppler imaging |
Q37854328 | Hemodynamic alterations in cirrhosis and portal hypertension |
Q36721334 | High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients. |
Q51823738 | Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantation. |
Q38249875 | Management of Complications of End-Stage Liver Disease in the Intensive Care Unit. |
Q47912085 | Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations |
Q83260371 | Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience |
Q89976306 | Relationship between Heart Disease and Liver Disease: A Two-Way Street |
Q35636735 | Reversible Cardiomyopathies |
Q37811399 | Reversible Cardiomyopathies—A Review |
Q27011341 | Role of cardiovascular intervention as a bridge to liver transplantation |
Q40511957 | Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt |
Q33758733 | The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients |
Search more.